IO Biotech Files 8-K on Financials and Operations
Ticker: IOBT · Form: 8-K · Filed: Mar 4, 2025 · CIK: 1865494
| Field | Detail |
|---|---|
| Company | Io Biotech, Inc. (IOBT) |
| Form Type | 8-K |
| Filed Date | Mar 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, operations, sec-filing
TL;DR
IO Biotech dropped an 8-K on March 4th covering financials and operations. Check it for the latest.
AI Summary
IO Biotech, Inc. filed an 8-K on March 4, 2025, reporting on its results of operations and financial condition. The filing also includes information related to Regulation FD disclosure and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Copenhagen, Denmark.
Why It Matters
This 8-K filing provides investors with crucial updates on IO Biotech's financial health and operational status, impacting investment decisions.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can significantly impact a company's stock price, requiring careful investor attention.
Key Numbers
- 001-41008 — SEC File Number (Identifies the company's filing with the SEC.)
- 87-0909276 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- IO Biotech, Inc. (company) — Registrant
- March 4, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Copenhagen, Denmark (location) — Principal Executive Offices
- +45 7070 2980 (phone_number) — Business Phone
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' but does not provide specific dollar amounts or detailed financial statements within the provided text.
What is the primary purpose of this 8-K filing for IO Biotech?
The primary purpose is to report on the company's results of operations and financial condition, as well as to provide Regulation FD disclosures and financial statements and exhibits.
When was this 8-K filing submitted?
The filing was submitted on March 4, 2025.
Where are IO Biotech's principal executive offices located?
IO Biotech's principal executive offices are located at Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.
What is the SIC code for IO Biotech?
The Standard Industrial Classification (SIC) code for IO Biotech is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 4, 2025 regarding IO Biotech, Inc. (IOBT).